Klenk, H
Quick Answer: GLP-1 receptor agonists are not licensed or supported by clinical evidence for rheumatoid arthritis treatment in the UK, and microdosing remains experimental without established safety or efficacy data
GLP-1 RAs: Why Everyones Talking About Them - and What Actually Matters / Continuing Education, Lectures and forums, Alumni Events / Virtual Pharmacology Updates for APPs with Katie George, DNP, AG-ACNP, UVA Health Adult-Gerontology
It is always better to ask than to delay care
Hannah, April 23, 2025 I absolutely love using Measured I absolutely loved using Measured
We only discovered the BMI requirements after researching the diagnostic criteria for GLP-1 prescriptions, but it is public information, so there's no reason to withhold it from consumers